Two non-randomised target trial emulations in patients with type 2 diabetes: SGLT-2i use was associated with lower chronic lower respiratory disease incidence than GLP-1RA (HR 0.87, 95% CI 0.79-0.96) and than DPP-4i (HR 0.95, 0.91-0.99).
RCT
Li et al. Association between sodium-glucose cotransporter 2 inhibitors and the risk of chronic lower respiratory disease in type 2 diabetes mellitus: findings from two target trial emulations